ANT Neuromeeting US Edition in Philadelphia, PA, April 10-11, 2024
For more than three decades, organized by ANT Neuro, ANT Neuromeeting has been a strong platform for fostering exceptional scientific discussions and exchange.
Throughout the years, the main objective has remained unchanged: bringing together scientists and clinicians, facilitating their interaction, and inspiring new advancements within their fields.
2024 marks the first ANT Neuromeeting to be organized by ANT North America and held in North America. Leading EEG and Neuromodulation experts from around the globe will join in the heart of Philadelphia.
Talks by leading experts, numerous opportunities to network and learn from peers, as well as workshops and equipment demonstrations make this annual event vibrant and immersive.
The sessions will include:
April 10: Pediatric EEG: Applications in Epilepsy, Neonatology, and Beyond (Morning) | EEG in Autism Research (Afternoon) | High-Density EEG workshop (Afternoon)
April 11: Closed Loop Neuromodulation (Morning) | Navigated Neuromodulation (Afternoon) | Robot Navigated TMS/EEG (Afternoon)
In addition to talks by renowned speakers, the meeting includes EEG and TMS product demonstrations and a rich social program, providing the opportunity to meet and exchange ideas with experts in the field.
More info on the event can be found here: https://campaign.ant-neuro.com/ant-neuromeeting-2024-us-edition
Registration can be made here: https://www.eventbrite.com/e/neuromeeting-2024-philadelphia-pa-tickets-776496059617
Please CONTACT US online or send an email at contact@neuronix.ca to receive a $100 discount code for your registration.
About ANT Neuro
ANT Neuro is a Dutch corporation specialized in the development, marketing and sales of medical and research applications. ANT Neuro was established in 1997 as a spin-off company of the University of Twente, Enschede. It now has offices located in Hengelo, The Netherlands; Berlin, Germany; London, UK; Philadelphia, USA; Melbourne, Australia; and Hong Kong, China.
ANT Neuro specializes in being a single-source provider of high-performance products within neuroscience research and neurodiagnostics. Applications include EEG, EMG, TMS and MEG technologies in cognitive Neuroscience, Neurology and Psychiatry.
Using ANT Neuro products, functional brain information is fused with anatomical scans to gain insight into the working mechanisms of cognition and a variety of brain disorders.
ANT Neuro is also the marketed brand under the umbrella of the neuromotion group.
The neuromotion group comprises ANT Neuro bv (Hengelo, The Netherlands), ANT Neuro GmbH (Berlin, Germany), ANT Neuro UK (London, United Kingdom), ANT North America (Philadelphia, USA), ANT Neuro Australia (Melbourne, Australia), ANT Asia Pacific (Hong Kong) and eemagine GmbH (Berlin, Germany).
While eemagine is responsible for the development, production and support of all ANT Neuro projects, takes care of a few key accounts and is an established organization for OEM development projects for third parties situated worldwide, ANT Neuro, together with ANT North America and ANT Asia Pacific, are responsible for the world-wide sales and marketing of eemagine’s neuroscience, neurocare, and neuromodulation products.